Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic
- PMID: 38419909
- PMCID: PMC10901147
- DOI: 10.14745/ccdr.v49i05a05
Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic
Abstract
Background: National responses to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic have been highly variable. We sought to explore the effectiveness of the Canadian pandemic response up to May 2022 relative to responses in four peer countries with similar political, economic and health systems, and with close historical and cultural ties to Canada.
Methods: We used reported age-specific mortality data to generate estimates of pandemic mortality standardized to the Canadian population. Age-specific case fatality, hospitalization, and intensive care admission probabilities for the Canadian province of Ontario were applied to estimated deaths, to calculate hospitalizations and intensive care admissions averted by the Canadian response. Health impacts were valued in both monetary terms, and in terms of lost quality-adjusted life years.
Results: We estimated that the Canadian pandemic response averted 94,492, 64,306 and 13,641 deaths relative to the responses of the United States, United Kingdom and France, respectively, and more than 480,000 hospitalizations relative to the United States. The United States pandemic response, if applied to Canada, would have resulted in more than $40 billion in economic losses due to healthcare expenditures and lost quality-adjusted life years. In contrast, an Australian pandemic response applied to Canada would have averted over 28,000 additional deaths and averted nearly $9 billion in costs.
Conclusion: Canada outperformed several peer countries that aimed for mitigation rather than elimination of SARS-CoV-2 in the first two years of the pandemic, with substantial numbers of lives saved and economic costs averted. However, a comparison with Australia demonstrated that an elimination focus would have saved Canada tens of thousands of lives as well as substantial economic costs.
Keywords: Canada; SARS-CoV-2; health economics; pandemic severity; public health; standardization.
Conflict of interest statement
Competing interests DNF has served on advisory boards related to influenza and SARS-CoV-2 vaccines for Seqirus, Pfizer, AstraZeneca and Sanofi-Pasteur Vaccines, and has served as a legal expert on issues related to COVID-19 epidemiology for the Elementary Teachers Federation of Ontario and the Registered Nurses Association of Ontario. ART was employed by the Public Health Agency of Canada when the research was conducted.
Figures



Similar articles
-
Impact of community mask mandates on SARS-CoV-2 transmission in Ontario after adjustment for differential testing by age and sex.PNAS Nexus. 2024 Feb 12;3(2):pgae065. doi: 10.1093/pnasnexus/pgae065. eCollection 2024 Feb. PNAS Nexus. 2024. PMID: 38463611 Free PMC article.
-
Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.Ann Intern Med. 2021 Jun;174(6):803-810. doi: 10.7326/M21-0510. Epub 2021 Mar 9. Ann Intern Med. 2021. PMID: 33683930 Free PMC article.
-
Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.JAMA Health Forum. 2021 Jul 30;2(7):e211749. doi: 10.1001/jamahealthforum.2021.1749. eCollection 2021 Jul. JAMA Health Forum. 2021. PMID: 35977202 Free PMC article.
-
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015. Tob Use Insights. 2015. PMID: 26242225 Free PMC article. Review.
-
The Minderoo-Monaco Commission on Plastics and Human Health.Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
Cited by
-
Clinical Outcomes and Healthcare Utilization in Patients Receiving Maintenance Dialysis After the Onset of the COVID-19 Pandemic in Ontario, Canada.Can J Kidney Health Dis. 2025 Mar 29;12:20543581251328077. doi: 10.1177/20543581251328077. eCollection 2025. Can J Kidney Health Dis. 2025. PMID: 40161414 Free PMC article.
-
Impact of community mask mandates on SARS-CoV-2 transmission in Ontario after adjustment for differential testing by age and sex.PNAS Nexus. 2024 Feb 12;3(2):pgae065. doi: 10.1093/pnasnexus/pgae065. eCollection 2024 Feb. PNAS Nexus. 2024. PMID: 38463611 Free PMC article.
-
Impact of adjustment for differential testing by age and sex on apparent epidemiology of SARS-CoV- 2 infection in Ontario, Canada.BMC Infect Dis. 2025 Apr 23;25(1):589. doi: 10.1186/s12879-025-10968-6. BMC Infect Dis. 2025. PMID: 40269768 Free PMC article.
-
Higher Post-Acute Health Care Costs Following SARS-CoV-2 Infection Among Adults in Ontario, Canada.J Multidiscip Healthc. 2024 Dec 5;17:5749-5761. doi: 10.2147/JMDH.S465154. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 39659735 Free PMC article.
References
-
- Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications . Eur J Epidemiol 2020;35(12):1123–38. 10.1007/s10654-020-00698-1 - DOI - PMC - PubMed
-
- Craft L. Japan has long accepted COVID’s airborne spread, and scientists say ventilation is key. CBS News; 2020. https://www.cbsnews.com/news/coronavirus-japan-has-long-accepted-covids-...
-
- Rouleau JL, Moyé LA, Pfeffer MA, Arnold JM, Bernstein V, Cuddy TE, Dagenais GR, Geltman EM, Goldman S, Gordon D, Hamm P, Klein M, Lamas GA, McCans J, McEwan P, Menapace FJ, Parker JO, Sestier F, Sussex B, Braunwald E; SAVE Investigators . A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med 1993;328(11):779–84. 10.1056/NEJM199303183281108 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous